Evaluation of α-amylase inhibitory activities of selected antidiabetic medicinal plants
Inhibitors of carbohydrate hydrolyzing enzymes such as α-amylase play an important role for the control of diabetes mellitus especially in patients with type 2 diabetes. In this study we selected ten antidiabetic medicinal plants, because they have been recommended to treat diabetes in traditional Iranian medicine, and screened them for α-amylase inhibitory activities. Among the tested samples, Camellia sinensis (Theaceae) leaf (IC50 = 1.54 mg/mL), Trigonella foenum-graecum (Leguminosae) seed (IC50 = 1.87 mg/mL) and leaf (IC50 = 1.92 mg/mL), and Urtica dioica (Urticaceae) leaf (IC50 = 1.89 mg/mL) revealed appreciable α-amylase inhibitory activities in a concentration-dependent manner. Furthermore, the most active sample, Camellia sinensis leaf, was partitioned by stepwise solvent–solvent extraction process and the inhibitory effect of each fraction on the α-amylase was tested. According to the results, the ethyl acetate fraction (IC50 = 0.53 mg/mL) and the residue (IC50 = 0.52 mg/mL) had the highest α-amylase inhibitory activities.
Keywordsα-Amylase inhibitors Antidiabetic medicinal plants Camellia sinensis Diabetes mellitus
We would like to thank Shahid Beheshti University of Medical Sciences for financial support of this project.
- Abesundara KJ, Matsui T, Matsumoto K (2004) alpha-Glucosidase inhibitory activity of some Sri Lanka plant extracts, one of which, Cassia auriculata, exerts a strong antihyperglycemic effect in rats comparable to the therapeutic drug acarbose. J Agric Food Chem 52:2541–2545PubMedCrossRefGoogle Scholar
- Bordia A, Verma SK, Srivastava KC (1997) Effect of ginger (Zingiber officinale Rosc.) and fenugreek (Trigonella foenumgraecum L.) on blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease. Prostaglandins Leukot Essent Fatty Acids 56:379–384PubMedCrossRefGoogle Scholar
- Funke I, Melzig MF (2006) Traditionally used plants in diabetes therapy–phytotherapeutics as inhibitors of α-amylase activity. Braz J Pharmacognosy 16:1–5Google Scholar